New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:37 EDTHTBXHeat Biologics to form CAB with immunotherapy, oncology experts
Heat Biologics announced the creation of a Clinical Advisory Board, or CAB, to actively design and guide its clinical trials and the appointment of four leading oncologists to serve on this board. Justin Stebbing, M.D., Ph.D. will serve as Chairman of the CAB and chief medical advisor to Heat. The CAB will work hand-in-hand with Heat's clinical team, led by Melissa Price, Ph.D., Vice President of Clinical and Regulatory Affairs. Dr. Stebbing will serve as lead advisor on the company's clinical trials.
News For HTBX From The Last 14 Days
Check below for free stories on HTBX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
07:14 EDTHTBXHeat Biologics reports Q2 EPS (44c), consensus (40c)
The company said, "The increase in the loss was primarily attributable to an increase of $160,380 in Research and Development expense, an increase of $658,252 in Clinical and Regulatory expense and an increase of $576,708 in General and Administrative expense."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use